-
公开(公告)号：WO2011126295A2
公开(公告)日：2011-10-13
申请号：PCT/KR2011/002402
申请日：2011-04-06
CPC classification number: A61Q19/08 , A61K8/97 , A61K2800/522 , A61Q19/02
Abstract: 본 발명은 약용 잎을 사용한 쌈 발효 추출물을 함유하는 피부 외용제 조성물에 관한 것으로, 보다 상세하게는 천연물을 약용 잎으로 싸거나 덮어서 발효시켜 제조된 쌈 발효 추출물을 함유하여 피부 항산화, 항노화, 미백 및 보습 효과가 탁월한 피부 외용제 조성물에 관한 것이다.
Abstract translation: 本发明涉及含有使用药用叶包装发酵提取物的外用皮肤用组合物，更具体地，涉及外用皮肤用组合物，其含有通过用药用叶包装或覆盖天然产物而制备的包装发酵提取物，并将其发酵 ，因此对于抗氧化剂，抗老化，美白和保湿效果而言，其对皮肤优异。
-
公开(公告)号：KR1020070002409A
公开(公告)日：2007-01-05
申请号：KR1020050057934
申请日：2005-06-30
Applicant: (주)아모레퍼시픽
CPC classification number: A61K8/97 , A61K8/0212 , A61Q19/08
Abstract: A cosmetic composition comprising the extract of Equisetum arvense L. as an effective ingredient is provided to promote growth of keratinocytes, remove reactive oxygen species, increase biosynthesis of procollagen type 1 by reducing biosynthesis of MMP-1(matrix metaloproteinase-1), and inhibit aging. The cosmetic composition for promoting growth of keratinocytes, removing reactive oxygen species, increasing biosynthesis of procollagen type 1 by reducing biosynthesis of MMP-1, or inhibiting aging comprises the extract of Equisetum arvense L. and at least one extract selected from Lonicera japonica Thunberg extract, Prunus armeniaca extract, Plantago asiatica extract and Coix lacryma-jobi extract, wherein the amount of the medicinal herb extract is 0.0001 to 25 wt.% based on the total weight of the composition; the medicinal herb extracts are prepared with water; and the composition further comprises 1,3-butyleneglycol.
Abstract translation: 提供了含有作为有效成分的马齿苋提取物的化妆品组合物，用于促进角质形成细胞的生长，去除活性氧，通过降低MMP-1（基质金属蛋白酶-1）的生物合成来增加1型前胶原的生物合成，抑制 老化。 用于促进角质形成细胞生长，去除活性氧的化妆品组合物，通过减少MMP-1的生物合成增加生物合成1型前胶原或抑制老化的化妆品组合物包括马齿苋提取物和至少一种选自金银花提取物（Lonicera japonica Thunberg extract）的提取物 ，山茱萸提取物，车前草提取物和枸杞提取物，其中药草提取物的量为组合物总重量的0.0001〜25重量％ 药草提取物用水制备; 并且组合物还包含1,3-丁二醇。
-
公开(公告)号：KR100629712B1
公开(公告)日：2006-09-29
申请号：KR1020040020401
申请日：2004-03-25
Applicant: (주)아모레퍼시픽
IPC: C07C239/14
Abstract: 본 발명은 하기 화학식 1로 표시되는 히드록삼산(Hydroxamic acid) 유도체 및 그 제조방법에 관한 것이다:
[화학식 1]
상기 식 중에서, R
1 및 R
2 는 수소, C
1-10 의 알킬 또는 C
3-6 의 알킬 고리이고;
R
3 는 CONH, NHCO, CONR
5 , 또는 NR
5 CO 이며, 이때, R
5 는 수소 또는 C
1-10 의 알킬이고; 및
R
4 는 -(CH)n- 이며, n = 0, 1이다.
또한 본 발명은 상기 화학식 1의 히드록삼산 유도체를 유효성분으로 함유하는 피부노화 방지용 피부 외용제 조성물에 관한 것이다.
레티노이드 * 레티노익산 수용체 * 히드록삼산 유도체 * 항노화 * 콜라겐 * 엘라스틴 * 콜라게나아제 발현억제 * 엘라스테이즈 발현억제 * 탄력 개선 * 피부 외용제-
公开(公告)号：KR101189989B1
公开(公告)日：2012-10-12
申请号：KR1020050057934
申请日：2005-06-30
Applicant: (주)아모레퍼시픽
CPC classification number: A61K8/97 , A61K8/0212 , A61Q19/08
Abstract: 본 발명은 유효성분으로 문형 추출물에 인동 추출물, 행인 추출물, 감국 추출물 및 의이인 추출물로 이루어진 군으로부터 선택된 하나 이상을 더 함유하는 조성물에 관한 것으로, 더 구체적으로는 각질형성세포 성장촉진 효과, 활성산소 소거효과, MMP-1의 생합성 감소를 통한 타입 1 프로콜라겐의 생합성촉진 효과 및 노화방지 효과를 가지는 조성물에 관한 것이다.
문형*인동*행인*감국*의이인*각질형성세포*활성산소*타입1 프로콜라겐-
公开(公告)号：KR1020110112231A
公开(公告)日：2011-10-12
申请号：KR1020110031692
申请日：2011-04-06
Applicant: (주)아모레퍼시픽
CPC classification number: A61Q19/08 , A61K8/97 , A61K2800/522 , A61Q19/02
Abstract: 본 발명은 약용 잎을 사용한 쌈 발효 추출물을 함유하는 피부 외용제 조성물에 관한 것으로, 보다 상세하게는 천연물을 약용 잎으로 싸거나 덮어서 발효시켜 제조된 쌈 발효 추출물을 함유하여 피부 항산화, 항노화, 미백 및 보습 효과가 탁월한 피부 외용제 조성물에 관한 것이다.
-
Patent Agency Ranking
公开(公告)号：KR1020050022251A
公开(公告)日：2005-03-07
申请号：KR1020040020401
申请日：2004-03-25
Applicant: (주)아모레퍼시픽
IPC: C07C239/14
Abstract: PURPOSE: Provided are a hydroxamic acid derivative which shows an antiaging effect and is improved in safety and stability to the skin stimulus and discoloration, its preparation method, and an antiaging skin preparation for external use and a collagenase and elastase expression inhibitor containing the derivative. CONSTITUTION: The hydroxamic acid derivative is represented by the formula 1, wherein R1 and R2 are H, a C1-C10 alkyl group or a C3-C6 cycloalkyl group; R3 is CONH, NHCO, CONR5 or NR5CO (wherein R5 is H or a C1-C10 alkyl group); and R4 is -(CH)n- (wherein n is 0 or 1). The method comprises the steps of reacting benzoic acid and methyl 4-aminobenzoate or 4-aminophenylacetic acid methyl ester or reacting aniline and monomethyl terephthalate, to prepare a benzamide compound; substituting the amino bond of the benzamide compound into an alkyl bond; hydrolyzing the methyl ester group to prepare an acid; and reacting the obtained acid with hydroxyl amine·HCl salt to prepare the hydroxamic acid derivative of the formula 1.
Abstract translation: 目的：提供一种异羟肟酸衍生物，其表现出抗衰老作用，并且改善了皮肤刺激和变色的安全性和稳定性，其制备方法和外用抗衰老皮肤制剂以及含有该衍生物的胶原酶和弹性蛋白酶表达抑制剂。 构成：异羟肟酸衍生物由式1表示，其中R 1和R 2是H，C 1 -C 10烷基或C 3 -C 6环烷基; R3是CONH，NHCO，CONR5或NR5CO（其中R5是H或C1-C10烷基）; 且R 4为 - （CH）n - （其中n为0或1）。 该方法包括使苯甲酸和4-氨基苯甲酸甲酯或4-氨基苯乙酸甲酯或苯胺与对苯二甲酸单甲酯反应制备苯甲酰胺化合物的步骤; 将苯甲酰胺化合物的氨基取代成烷基键; 水解甲基酯以制备酸; 并使所得酸与羟胺·HCl盐反应制备式1的异羟肟酸衍生物。
-
公开(公告)号：KR101805004B1
公开(公告)日：2017-12-07
申请号：KR1020110031692
申请日：2011-04-06
Applicant: (주)아모레퍼시픽
CPC classification number: A61Q19/08 , A61K8/97 , A61K2800/522 , A61Q19/02
Abstract: 본발명은약용잎을사용한쌈 발효추출물을함유하는피부외용제조성물에관한것으로, 보다상세하게는천연물을약용잎으로싸거나덮어서발효시켜제조된쌈 발효추출물을함유하여피부항산화, 항노화, 미백및 보습효과가탁월한피부외용제조성물에관한것이다.
-
公开(公告)号：KR100716887B1
公开(公告)日：2007-05-09
申请号：KR1020050004715
申请日：2005-01-18
Applicant: (주)아모레퍼시픽
IPC: C12P17/06
CPC classification number: C12P17/06
Abstract: 본 발명은 카멜리아시드 A(camelliaside A) 또는 카멜리아시드 B(camelliaside B)를 포함하는 캄페롤 배당체로부터 효소 또는 상기 효소를 생산하는 미생물을 이용하여 캄페롤(kaempferol)을 분리하는 것을 특징으로 하며, 상기 방법을 이용하면, 식물 특히, 녹차 씨와 녹차 잎으로부터 주요한 생리활성물질인 캄페롤을 대량으로 생산할 수 있다.
캄페롤, 배당체, 식물, 추출물, 산, 염기, 효소, 미생물, 카멜리아시드, 녹차 씨, 녹차 잎-
公开(公告)号：KR1020060113110A
公开(公告)日：2006-11-02
申请号：KR1020050035986
申请日：2005-04-29
Applicant: (주)아모레퍼시픽
IPC: C07C239/18
CPC classification number: C07C259/06 , A61K8/42 , A61Q19/08 , C07C259/10
Abstract: Provided are a hydroxamic acid derivative which shows an antioxidizing effect and a collagen biosynthesis enhancing effect, its preparation method, and a skin preparation composition for external use containing the derivative. The hydroxamic acid derivative is represented by the formula 1, wherein R1 and R2 is a C1-C10 alkyl group; R3 is -(CH)n-; n is 0 or 1; and R4 is H or a methyl group. The method comprises the steps of reacting a 3,4-dialkoxybenzoic acid and methyl 4-aminobenzoate or methyl 4-aminophenyl acetate to prepare a benzamide compound; hydrolyzing a methyl ester group of the benzamide compound to prepare an acid; and reacting the acid with hydroxylamineÀHCl salt or N-methyl hydroxylamineÀHCl salt to prepare the hydroxamic acid derivative of the formula 1.
Abstract translation: 提供显示抗氧化作用和胶原生物合成增强效果的异羟肟酸衍生物，其制备方法和含有该衍生物的外用皮肤制剂组合物。 异羟肟酸衍生物由式1表示，其中R 1和R 2是C 1 -C 10烷基; R3是 - （CH）n-; n为0或1; R4为H或甲基。 该方法包括使3,4-二烷氧基苯甲酸与4-氨基苯甲酸甲酯或4-氨基苯基乙酸甲酯反应制备苯甲酰胺化合物的步骤; 水解苯甲酰胺化合物的甲基酯以制备酸; 并使酸与羟胺-HCl盐或N-甲基羟胺-HCl盐反应以制备式1的异羟肟酸衍生物。
-
公开(公告)号：KR1020030041433A
公开(公告)日：2003-05-27
申请号：KR1020010072226
申请日：2001-11-20
Applicant: (주)아모레퍼시픽
IPC: A61K31/198
Abstract: PURPOSE: A composition for transdermal administration comprising L-arginine which has excellent therapeutic effect and presents no adverse effects even when administered in excess as a main drug is provided. The composition is an external application which overcomes the defects of conventional injections or oral therapeutic agents and effective in treatment of erectile dysfunction and frigidity. CONSTITUTION: A preparation for transdermal administration contains 1 to 20% by weight of L-arginine, 1 to 30% by weight of a skin permeation enhancer, a pharmaceutically acceptable carrier and additionally 1 to 80% by weight of one or more additives selected from a solubilizing aid, a softening agent, a surfactant, a thickening agent and a pH controller. The preparation is applied to the peripheral surface of the penis and the clitoris in a single dose of about 0.1 to 2g.
Abstract translation: 目的：用于透皮给药的组合物，其包含L-精氨酸，其具有优异的治疗效果，并且即使以过量作为主要药物也不会产生不良反应。 该组合物是克服常规注射或口服治疗剂的缺陷并有效治疗勃起功能障碍和寒冷的外部应用。 构成：用于透皮给药的制剂含有1至20重量％的L-精氨酸，1至30重量％的皮肤渗透促进剂，药学上可接受的载体，另外1至80重量％的一种或多种添加剂选自 增溶助剂，软化剂，表面活性剂，增稠剂和pH控制剂。 该制剂以约0.1至2g的单次剂量施用于阴茎和阴蒂的外周表面。
-
-
-
-
-
-
-
-
-
Search Results
13
records
(took 0.027 seconds)
